Overview
Orofaciodigital syndrome (OFD syndrome) refers to a heterogeneous group of rare genetic disorders characterized by abnormalities of the oral cavity (mouth), face, and digits (fingers and toes). Orphanet code 140997 represents the broader grouping of orofaciodigital syndromes, which encompasses multiple subtypes (historically numbered OFD type I through at least type XIV). Common oral features include cleft lip, cleft palate, lobulated or bifid tongue, lingual hamartomas, accessory frenula, and dental anomalies. Facial features may include facial asymmetry, hypertelorism (widely spaced eyes), micrognathia, and a broad nasal root. Digital abnormalities frequently include brachydactyly (short digits), syndactyly (fused digits), clinodactyly (curved digits), and polydactyly (extra digits). Depending on the specific subtype, additional organ systems may be affected, including the central nervous system (structural brain malformations such as cerebellar abnormalities, corpus callosum agenesis, and intellectual disability), kidneys (polycystic kidney disease, particularly in OFD type I), and skeleton. OFD type I (Papillon-Léage-Psaume syndrome) is the most well-characterized subtype and is caused by pathogenic variants in the OFD1 gene; it follows X-linked dominant inheritance and is typically lethal in males. Other subtypes may follow autosomal recessive inheritance and involve genes related to ciliary function, as many OFD syndromes are classified as ciliopathies. There is currently no cure for orofaciodigital syndromes. Management is multidisciplinary and symptomatic, involving surgical correction of oral clefts and digital malformations, dental care, speech therapy, monitoring of renal function, and neurodevelopmental support when needed. Genetic counseling is recommended for affected families to clarify the specific subtype and recurrence risk.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
2 eventsUniversity of Bern — NA
Krishnadevaraya College of Dental Sciences & Hospital — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Orofaciodigital syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Orofaciodigital syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Orofaciodigital syndrome.
Community
No community posts yet. Be the first to share your experience with Orofaciodigital syndrome.
Start the conversation →Latest news about Orofaciodigital syndrome
Disease timeline:
New recruiting trial: Surgical Treatment of Peri-implantitis With Adjunctive Application of Platelet Rich Fibrin (PRF)
A new clinical trial is recruiting patients for Orofaciodigital syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Orofaciodigital syndrome
What is Orofaciodigital syndrome?
Orofaciodigital syndrome (OFD syndrome) refers to a heterogeneous group of rare genetic disorders characterized by abnormalities of the oral cavity (mouth), face, and digits (fingers and toes). Orphanet code 140997 represents the broader grouping of orofaciodigital syndromes, which encompasses multiple subtypes (historically numbered OFD type I through at least type XIV). Common oral features include cleft lip, cleft palate, lobulated or bifid tongue, lingual hamartomas, accessory frenula, and dental anomalies. Facial features may include facial asymmetry, hypertelorism (widely spaced eyes), m
At what age does Orofaciodigital syndrome typically begin?
Typical onset of Orofaciodigital syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Orofaciodigital syndrome?
16 specialists and care centers treating Orofaciodigital syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.